ID
12003
Description
Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT02500706
Link
https://clinicaltrials.gov/show/NCT02500706
Keywords
Versions (1)
- 8/31/15 8/31/15 -
Copyright Holder
ODM derived from: https://clinicaltrials.gov/show/NCT02500706
Uploaded on
August 31, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes NCT02500706
Eligibility Diabetes NCT02500706
- StudyEvent: Eligibility
Description
Exclusion Criteria
Description
myocardial infarction; unstable angina; hospitalization; stroke
Data type
boolean
Alias
- UMLS CUI [1]
- C0027051
- UMLS CUI [2]
- C0002965
- UMLS CUI [3]
- C0007787
- UMLS CUI [4]
- C0038454
Description
new york heart association classification; class iv; planned
Data type
boolean
Alias
- UMLS CUI [1]
- C1882087
- UMLS CUI [2]
- C3203629
Description
ketoacidosis; screening; diabetic; visit; last
Data type
boolean
Alias
- UMLS CUI [1]
- C0011880
Description
Inclusion Criteria
Similar models
Eligibility Diabetes NCT02500706
- StudyEvent: Eligibility
C0682069 (UMLS CUI [2])
C0002965 (UMLS CUI [2])
C0007787 (UMLS CUI [3])
C0038454 (UMLS CUI [4])
C3203629 (UMLS CUI [2])
No comments